Naproxen Use in Pediatric Pain Management

Indications for Naproxen in Pediatric Patients

Naproxen is recommended as adjuvant therapy for pain and inflammation in children with conditions like juvenile idiopathic arthritis (JIA) 1
For postoperative pain management in pediatric patients, rectal, oral, or intravenous NSAIDs (including naproxen) are recommended during the entire postoperative period 3, 4
The American Academy of Pediatrics and other guideline societies recommend NSAIDs, including naproxen, for managing growing pains in pediatric patients, though they should be used judiciously 5

NSAID adjuvant therapy requires an adequate trial period of at least 8 weeks for conditions like JIA, given the time course to response of about 1 month 1

Naproxen is the preferred NSAID over other selective COX-1 or COX-2 inhibitors due to its established efficacy and safety profile in children, as recommended by the American College of Rheumatology 1, 2
The recommendation of naproxen as first-choice NSAID is based on evidence-supported efficacy and safety profile, as well as clinical expertise from the American Academy of Pediatrics 1

For mild to moderate pain, consider naproxen as a first-line NSAID option, as recommended by the American College of Rheumatology 1, 2
For postoperative pain management, consider combination with paracetamol for enhanced effect, as suggested by the American Society of Anesthesiologists 4
For more severe pain, use naproxen as an adjunct to opioid analgesia, as recommended by the American Society of Anesthesiologists 3

If naproxen is contraindicated or unavailable, alternative NSAIDs can be used based on their efficacy, safety profile, and FDA or EMA approval for pediatric use, as recommended by the American Academy of Pediatrics 1
For chronic inflammatory conditions like JIA, naproxen should not delay the introduction of disease-modifying antirheumatic drugs (DMARDs), as recommended by the American College of Rheumatology 1
Acetylsalicylic acid is not recommended for children due to controversial efficacy, safety concerns, and risks of toxicity, as stated by the American Academy of Pediatrics 1